Inhibrx Biosciences (INBX) Income Statement: Revenue & Earnings

Inhibrx Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Inhibrx Biosciences, Inc. income statement - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.20	0.19	0.10
Gross Profit	-0.20	-0.19	-0.10
Operating Expenses
Research & Development	0.20	0.19	0.10
Selling, General & Administrative	0.13	0.03	0.02
Operating Expenses	0.33	0.03	0.02
Operating Income	-0.33	-0.22	-0.12
Other Income/Expense
Interest Income	0.01	0.01	0.00
Interest Expense	0.01	-0.03	0.00
Other Income/Expense	2.02	0.00	0.00
Income
Income Before Tax	1.69	-0.24	-0.12
Income Tax Expense	0.00	0.00	0.00
Net Income	1.69	-0.24	-0.12
Net Income - Continuous Operations	1.69	-0.24	-0.12
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	1.70	-0.22	-0.11
EBIT	1.70	-0.22	-0.12
Depreciation & Amortization	0.00	0.00	0.00
Earnings Per Share
Basic EPS	114.00	-20.00	-3.00
Diluted EPS	113.00	-20.00	-3.00
Basic Shares Outstanding	0.01	0.01	0.04
Diluted Shares Outstanding	0.01	0.01	0.04